26 February 2020 Siobhn Talbot Mark Garvey Group Managing Director - - PowerPoint PPT Presentation

26 february 2020 siobh n talbot mark garvey
SMART_READER_LITE
LIVE PREVIEW

26 February 2020 Siobhn Talbot Mark Garvey Group Managing Director - - PowerPoint PPT Presentation

26 February 2020 Siobhn Talbot Mark Garvey Group Managing Director Group Finance Director This presentation contains forward-looking statements. These statements have been made by the Directors in good faith based on the information


slide-1
SLIDE 1

Siobhán Talbot

Group Managing Director

Mark Garvey

Group Finance Director

26 February 2020

slide-2
SLIDE 2

Glanbia plc FY 2019 Results 2

This presentation contains forward-looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval of this presentation. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward-looking

  • statements. The Directors undertake no obligation to update any forward-

looking statements contained in this presentation, whether as a result of new information, future events, or otherwise.

slide-3
SLIDE 3

Glanbia plc FY 2019 Results 3

EPS 88.10c; in line with guidance but below ambition Revenue growth driven by GN & acquisitions Earnings impacted by challenges in GPN Seeking authority for Share Buyback Programme Full year dividend increased by 10%. Payout ratio 30%

Executing a clear strategy to address GPN challenges, drive top & bottom line momentum

Operating cash conversion 86%

slide-4
SLIDE 4

Continuing evolution of GN Nutritional Solutions through organic growth & strategic acquisitions

Ongoing execution Organisational review

Completed comprehensive review of GPN strategy across Brand, Geography & Operational model

Regain growth momentum in GPN

4

Actions

Glanbia plc FY 2019 Results

JVs executing planned strategy Group-wide projects initiated to target productivity benefits from leveraging scale Series of initiatives underway to deliver top- line momentum & margin improvement

slide-5
SLIDE 5
slide-6
SLIDE 6

Glanbia plc FY 2019 Results 6

Revenue

€1,363.8m

+11.0% cc

EBITA

€146.4m

  • 19.6% cc

Growing consumer reach

Driven by Slimfast Margin 10.7%

  • 410 bps

Challenging year on organic revenue & EBITA margin Revenue growth driven by Slimfast Margin decline driven by mix and negative

  • perating leverage due to lower LFL revenue

cc – Constant Currency Definitions and reconciliations of non-IFRS metrics can be found in the Appendix of this presentation and further information can be found in the Financial Statements and Glossary

slide-7
SLIDE 7

ON & Slimfast key platform brands, 69% of branded portfolio Exiting US Contract business Streamlining product portfolios – SKU rationalisation Refining approach to innovation Business re-organised

  • NA Performance Nutrition
  • NA Lifestyle
  • International
  • DTC

Talent investment across the business Detailed market-by-market review completed Responding to changing market dynamics Improving routes-to-market in India & Brazil Optimising the supply chain

7

Plan to drive revenue growth & margin improvement

Glanbia plc FY 2019 Results

Regaining growth momentum in the branded business

Targeting 200+ bps margin improvement by 2022

Brand Route-to-market Re-organisation

NA – North America DTC – Direct-to-Consumer

slide-8
SLIDE 8

Glanbia plc FY 2019 Results 8

GPN’s platform brands which are key category players $655m brand - Globally GPN’s platform Performance Nutrition brand Globally Key formats - RTM Protein & Energy $325m brand – US & UK GPN’s platform brand in US and UK lifestyle nutrition Key formats – RTD & RTE

slide-9
SLIDE 9

Glanbia plc FY 2019 Results 9

39% of total GPN sales (€538m) ON key platform brand ON consumption in 2019* mid-single digit growth BSN & Isopure focused on specific channels & consumer segments Positive pricing in H2

*NA measured channels captures 72% of total ON North America net sales

slide-10
SLIDE 10

29% of total GPN sales (€392m) Slimfast key platform brand think! re-launched in RTE category Slimfast 2019 consumption grew by 49% in measured channels* Amazing Grass playing into Plant Nutrition trend

*NA measured channels captures 73% of total Slimfast North America net sales Glanbia plc FY 2019 Results 10

slide-11
SLIDE 11

26% of total GPN sales (€359m) (13% Europe / 13% RoW) Double-digit decline in 2019 ON key platform brand Business simplification commenced in 2019 Priority markets China, India, Oceania, UK and Western Europe

Glanbia plc FY 2019 Results 11

slide-12
SLIDE 12

Glanbia plc FY 2019 Results 12

Engaging Consumers Working with e- Commerce leaders Building in-house DTC capability

ON campaign 1200 individual pieces of digital content deployed across 25 markets

Online is GPN’s largest channel and digital capability is enabling growth worldwide

Installed Hybris e-Commerce platform to enable scaling

  • f business

Expanding in 2020 to be in a total of 14 markets 6% of total GPN sales

Other channels 74% Online 26%

2019

GPN Revenue

slide-13
SLIDE 13

GN Operating Review

slide-14
SLIDE 14

Glanbia plc FY 2019 Results 14

Expanding portfolio Revenue

€744.9m

+23.4% cc

EBITA

€100.0m

+7.1% cc

Driven by

  • rganic growth

& acquisition Margin 13.4%

  • 210 bps

Revenue growth driven by premix in Asia, healthy snacking solutions & Watson acquisition EBITA growth driven by volume

Strong growth in value-added functional ingredients

EBITA margin impacted by sales mix & tariff headwinds Innovation continues to be a key driver of growth

cc – Constant Currency Definitions and reconciliations of non-IFRS metrics can be found in the Appendix of this presentation and further information can be found in the Financial Statements and Glossary

slide-15
SLIDE 15

Glanbia plc FY 2019 Results 15

Acquired in Q1 2019 Complementary technologies & supply chain to Nutritional Solutions Customers across personal care and food sectors Integration on track Healthy snacking technology development

  • High protein solutions
  • Crisp technology
  • Cereals & plant-based solutions

Enhanced solutions capability

Innovation

slide-16
SLIDE 16

Driven by capacity expansion Margin 1.7%

+10 bps

Revenue

€1,767.0m

+18.5% cc

EBITA

€30.4m

+23.6% cc

Glanbia plc FY 2019 Results 16

Scale dairy operations

Revenue growth driven by Southwest Cheese expansion and positive dairy markets Margin expansion driven by good operating performance Stable revenue & profit stream continued in FY 2019

Strong operational performance

cc – Constant Currency Definitions and reconciliations of non-IFRS metrics can be found in the Appendix of this presentation and further information can be found in the Financial Statements and Glossary

slide-17
SLIDE 17

JVs Operating Review

slide-18
SLIDE 18

Glanbia plc FY 2019 Results 18

Scale dairy operations Revenue

€1,476.1m

+12.9% cc

Share of PAT

€48.6m

+€3.3m

Driven by capacity expansion PAT €48.6m

+5.9% cc Revenue growth driven by volume across all Joint Ventures PAT growth of 5.9% driven by capacity expansion and good operating performance New JV in Ireland to be commissioned by end of 2020

Revenue and margin growth

New JV in Michigan USA to be commissioned by Q3 2021

cc – Constant Currency Definitions and reconciliations of non-IFRS metrics can be found in the Appendix of this presentation and further information can be found in the Financial Statements and Glossary

slide-19
SLIDE 19
slide-20
SLIDE 20

Glanbia plc FY 2019 Results 20

2019 results summary Pre-exceptional €'m Reported currency Constant currency

2019 2018 Change Change Revenue (Wholly-owned) 3,875.7 3,170.5¹ 705.2 16.6% EBITA (Wholly-owned) 276.8 284.9 (8.1) (7.8%) EBITA margin 7.1% 9.0%

  • 190 bps
  • 190 bps

Amortisation (60.9) (45.9) (15.0) Net Finance Costs (26.3) (17.5) (8.8) Share of Joint Ventures 48.6 45.3 3.3 Income Tax (23.4) (32.8) 9.4 Profit for the period (pre-exceptional) 214.8 234.0 (19.2) Adjusted EPS 88.10 91.01 (2.91) (7.7%) Basic EPS 61.04 79.28 (18.24) (26.6%)

Drivers of wholly-owned Revenue growth

  • 9.9% contribution from acquisitions
  • 6.6% increase in pricing

Effective tax rate of 12.3%

(2018: 14.8%)

  • Primarily driven by geographic mix of

profits

EBITA margin impacted by

  • Negative operating leverage
  • Impact of product mix
  • Tariff headwinds

Definitions and reconciliations of non-IFRS metrics can be found in the Appendix of this presentation and further information can be found in the Financial Statements and Glossary 1 – Restated to reflect the adoption of IFRS 15

slide-21
SLIDE 21

Glanbia plc FY 2019 Results 21

€1,179.6m €1,363.8m

FY18 FX Volume Price Acquisition FY19

Challenging markets impacting volume – Review completed, actions to address under way

4.2% (9.0%) (0.6%) 20.6%

slide-22
SLIDE 22

Glanbia plc FY 2019 Results

€577.0m €744.9m

FY18 FX Volume Price Acquisition FY19

Nutritional Solutions

€1,413.9m €1,767.0m

FY18 FX Volume Price FY19

US Cheese

22

Organic growth with strong benefit from Watson acquisition

4.6% 7.0% 3.8% 12.6% 5.5% 4.9% 13.6%

slide-23
SLIDE 23

Glanbia plc FY 2019 Results 23

Exceptional Items 2019 €'000 Organisation redesign costs 12.7 Asset impairments 17.3 Acquisition integration costs 6.8 Brexit related costs 2.3 Total exceptional charge before taxation 39.1 Exceptional tax credit (4.5) Total exceptional charge after taxation 34.6 Organisation Redesign

  • To position GPN for future growth

Acquisition Integration

  • Costs related to the integration of

Slimfast & Watson

Asset Impairment – Business Simplification

  • Rationalisation of 35% of GPN total

SKUs completed

Brexit mitigation Initiatives commenced to restore growth in GPN

slide-24
SLIDE 24

Glanbia plc FY 2019 Results 24

Maintaining strong cash flow generation

FY19 EBITDA Working Capital Business Sustaining Capex FY19 Operating Cash Flow Net Interest & Tax Dividends from JVs Pension Other FY19 Free Cash Flow

€324.9m (€24.9m) (€20.1m) €279.9m (€74.1m) €35.3m (€7.6m) (€2.0m) €231.5m

OCF – Operating Cash Flow Definitions and reconciliations of non-IFRS metrics can be found in the Appendix of this presentation and further information can be found in the Financial Statements and Glossary

slide-25
SLIDE 25

Glanbia plc FY 2019 Results 25

€24m €16m €20m €49m €46m €56m €168m €313m €61m €42m €48m

2017 2018 2019

Sustaining Capex Strategic Capex Acquisitions Investments in JVs

Strategic projects to benefit product and proposition Investment in innovation and online platforms to enhance DTC offering Expansion of manufacturing facilities ROCE

13.2% 10.9%

2018 2019

€185m €417m €241m

Within target range of 10% - 13% Acquisition of Watson

slide-26
SLIDE 26

Glanbia plc FY 2019 Results

Balance Sheet KPI's FY 2019 FY 2018

Net Debt €614.3m €576.7m Net Debt / Adj. EBITDA 1.71x 1.55x

  • Adj. EBIT / Net Financing Costs

9.3x 14.8x

26

Well positioned for future growth Higher debt due to acquisitions and investments Well within covenants with ample headroom to finance further activity Strong cash flow will enable de-leveraging

ROCE – Return on Capital Employed Definitions and reconciliations of non-IFRS metrics can be found in the Appendix of this presentation and further information can be found in the Financial Statements and Glossary

slide-27
SLIDE 27

Glanbia plc FY 2019 Results 27

Efficient Balance Sheet Strong Operating Cash flow Generation ROCE Range of 10% - 13%

Capex Dividend M&A Additional Returns

Investments which support growth Complementary businesses Payout ratio in the range 25% - 35% Share Buyback

slide-28
SLIDE 28
slide-29
SLIDE 29

Glanbia plc FY 2019 Results 29

Returning GPN to sustainable topline growth in 2020 Targeting GPN margin growth of 200+ bps by 2022 Focused on creating shareholder value Commenced Group-wide productivity review

slide-30
SLIDE 30

30

  • Avg. EPS Growth

5% - 10%

ROCE – Return on Capital Employed Definitions and reconciliations of non-IFRS metrics can be found in the Appendix of this presentation and further information can be found in the Financial Statements and Glossary Average adjusted EPS on a constant currency basis over the 2020 – 2022 period

2020 - 2022

Cash conversion

>80%

ROCE

10% - 13%

Dividend payout

25% - 35%

Total Group Revenue by 2022

€6bn

Glanbia plc FY 2019 Results

slide-31
SLIDE 31

Earnings Operating Cash Conversion

Adjusted EPS

Broadly in line with prior year on a constant currency basis Greater than

80%

31

Rebuilding Growth Momentum

Glanbia plc FY 2019 Results

slide-32
SLIDE 32

Questions

slide-33
SLIDE 33
slide-34
SLIDE 34

Glanbia plc FY 2019 Results 34

The Group reports certain performance measures that are not defined under IFRS but which represent additional measures used by the Board of Directors and the Glanbia Operating Executive in assessing performance and for reporting both internally and to shareholders and other external users. The Group believes that the presentation of these non-IFRS performance measures provides useful supplemental information which, when viewed in conjunction with our IFRS financial information, provides readers with a more meaningful understanding of the underlying financial and operating performance of the Group.

  • 1. While the Group reports its results in euro, it generates a significant proportion of its earnings in currencies other than euro, in particular US dollar. Constant currency reporting is

used by the Group to eliminate the translational effect of foreign exchange on the Group's results. To arrive at the constant currency year-on-year change, the results for the prior year are retranslated using the average exchange rates for the current year and compared to the current year reported numbers

  • 2. The Group has a number of strategically important Equity accounted investees (Joint Ventures) which when combined with the Group’s wholly-owned businesses give an important

indication of the scale and reach of the Group’s operations. Total Group is used to describe certain financial metrics such as Revenue and EBITA when they include both the wholly-

  • wned businesses and the Group's share of Equity accounted investees
  • 3. Revenue comprises sales of goods and services of the wholly-owned businesses to external customers net of value-added tax, rebates and discounts
  • 4. EBITA is defined as earnings before interest, tax and amortisation
  • 5. EBITA margin is defined as EBITA as a percentage of revenue
  • 6. EBITDA is defined as earnings before interest, tax, depreciation (net of grant amortisation) and amortisation
  • 7. Adjusted EPS is defined as the net profit attributable to the equity holders of Glanbia plc, before exceptional items and intangible asset amortisation (excluding amortisation of

software costs) net of related tax, divided by the weighted average number of ordinary shares in issue during the year. The Group believes that adjusted EPS is a better measure of underlying performance than Basic EPS as it excludes exceptional items (net of related tax) that are not related to ongoing operational performance and intangible asset amortisation, which allows better comparability of companies that grow by acquisition to those that grow organically

  • 8. Net debt : adjusted EBITDA is calculated as net debt at the end of the period divided by adjusted EBITDA. Net debt is calculated as total financial liabilities less cash and cash
  • equivalents. Adjusted EBITDA is calculated as EBITDA for the wholly-owned businesses plus dividends received from Equity accounted investees, and in the event of an acquisition in

the year, includes pro-forma EBITDA as though the acquisition date had been at the beginning of the year. Adjusted EBITDA is a rolling 12 month measure

slide-35
SLIDE 35

Glanbia plc FY 2019 Results 35

  • 9. Adjusted EBIT: net finance cost is calculated as pre-exceptional earnings before interest and tax plus dividends received from Equity accounted investees divided by net finance cost.

Net finance cost comprises finance costs less finance income per the Group Income Statement plus capitalised borrowing costs. Adjusted EBIT and net finance cost are rolling 12 month measures

  • 10. The Group has adopted an income statement format that seeks to highlight significant items within the Group results for the year. Such items may include impairment of assets,

adjustments to contingent consideration, material acquisition integration costs, restructuring costs, profit or loss on disposal or termination of operations, material acquisition costs, litigation settlements, legislative changes, gains or losses on defined benefit pension plan restructuring and profit or loss on disposal of investments. Judgement is used by the Group in assessing the particular items which by virtue of their scale and nature should be disclosed in the income statement and notes as exceptional items

  • 11. Volume increase/(decrease) represents the impact of sales volumes within the revenue movement year-on-year, excluding volume from acquisitions, on a constant currency basis.

Pricing increase/(decrease) represents the impact of sales pricing within the revenue movement year-on-year, excluding acquisitions, on a constant currency basis

  • 12. Like-for-like branded revenue growth represents the sales growth / (decline) year-on-year on branded sales, excluding acquisitions, on a constant currency basis
  • 13. The effective tax rate is defined as the pre-exceptional income tax charge divided by the profit before tax less share of results of Equity accounted investees
  • 14. The Group defines business sustaining capital expenditure as the expenditure required to maintain/replace existing assets with a high proportion of expired useful life. This

expenditure does not attract new customers or create the capacity for a bigger business. It enables the Group to keep running at current throughput rates but also keep pace with regulatory and environmental changes as well as complying with new requirements from existing customers

  • 15. The Group defines strategic capital expenditure as the expenditure required to facilitate growth and generate additional returns for the Group. This is generally expansionary

expenditure beyond what is necessary to maintain the Group’s current competitive position

  • 16. Operating cash conversion is defined as Operating Cash Flow (OCF) divided by pre-exceptional EBITDA. Cash conversion is a measure of the Group’s ability to convert trading

profits into cash and is an important metric in the Group’s working capital management programme

  • 17. ROCE is defined as the Group’s earnings before interest, and amortisation (net of related tax) plus the Group’s share of the results of Equity accounted investees after interest and

tax divided by capital employed. Capital employed comprises the sum of the Group’s total assets plus cumulative intangible asset amortisation less current liabilities less deferred tax liabilities excluding all financial liabilities, retirement benefit assets and cash. It is calculated by taking the average of the relevant opening and closing balance sheet amounts

  • 18. Dividend payout ratio is defined as the annual dividend per ordinary share divided by the adjusted Earnings Per Share
slide-36
SLIDE 36

Glanbia plc FY 2019 Results 36

€'m Reported Constant currency Adjusted Earnings Per Share FY 2019 FY 2018 FY 2018 Profit attributable to the equity holders of the Company 180.2 234.0 245.5 Exceptional Items 34.6 Profit attributable to the equity holders of the Company – pre-exceptional 214.8 234.0 245.5 Amortisation (net of tax) 45.3 34.6 36.3 Adjusted net income 260.1 268.6 281.8 Weighted average number of ordinary shares in issue (millions) 295.2 295.2 295.2 Adjusted Earnings Per Share (cent) 88.10c 91.01c 95.49c

slide-37
SLIDE 37

Glanbia plc FY 2019 Results 37

€'m Reported Constant currency Glanbia Performance Nutrition FY 2019 FY 2018 FY 2018 % Change Revenue 1,363.8 1,179.6 1,228.7 +11.0% EBITA 146.4 173.1 182.2

  • 19.6%

EBITA margin 10.7% 14.7% 14.8%

  • 410 bps

€'m Reported Constant currency Glanbia Nutritionals FY 2019 FY 2018 FY 2018 % Change Revenue 2,511.9 1,990.9 2,095.4 +19.9% EBITA 130.4 111.8 118.0 +10.5% EBITA margin 5.2% 5.6% 5.6%

  • 40 bps

Following implementation of IFRS 15 prior year revenue was restated to reflect the impact of recognising sales from Glanbia’s Joint Venture Southwest Cheese. The impact was to increase prior year sales in Glanbia Nutritionals by €784 million in FY 2018; there was no change to EBITA following this restatement

slide-38
SLIDE 38

Glanbia plc FY 2019 Results 38

€'m Reported Constant currency Nutritional Solutions FY 2019 FY 2018 FY 2018 % Change Revenue 744.9 577.0 603.7 +23.4% EBITA 100.0 88.6 93.4 +7.1% EBITA margin 13.4% 15.4% 15.5%

  • 210 bps

€'m Reported Constant currency US Cheese FY 2019 FY 2018 FY 2018 % Change Revenue 1,767.0 1,413.9 1,491.7 +18.5% EBITA 30.4 23.2 24.6 +23.6% EBITA margin 1.7% 1.6% 1.6% +10 bps

Following implementation of IFRS 15 prior year revenue has been restated above to reflect the impact of recognising sales from Glanbia’s Joint Venture Southwest Cheese. The impact was to increase prior year sales in Nutritional Solutions and US Cheese by €50 million and €734 million respectively for FY 2018; there was no change to EBITA following this restatement

slide-39
SLIDE 39

Glanbia plc FY 2019 Results 39

€'m Reported Constant currency Total Group Revenue FY 2019 FY 2018 FY 2018 % Change Glanbia Performance Nutrition 1,363.8 1,179.6 1,228.7 +11.0% Glanbia Nutritionals 2,511.9 1,990.9 2,095.4 +19.9% Wholly Owned Revenue 3,875.7 3,170.5 3,324.1 +16.6% Equity accounted investees 1,476.1 1,283.8 1,307.3 +12.9% IFRS 15 Consolidation adjustment (539.3) (415.1) (437.2) Total Group 4,812.5 4,039.2 4,194.2 +14.7% €'m Reported Constant currency Joint Ventures FY 2019 FY 2018 FY 2018 % Change Revenue 1,476.1 1,283.8 1,307.3 +12.9% EBITA 73.6 65.8 67.1 +9.7% EBITA margin 5.0% 5.1% 5.1%

  • 10 bps

Share of JVs PAT 48.6 45.3 45.9 +5.9%

Following implementation of IFRS 15 prior year revenue was restated to reflect the impact of recognising sales from Glanbia’s Joint Venture Southwest Cheese. The impact was to increase prior year sales in Glanbia Nutritionals by €784 million in FY 2018; there was no change to EBITA following this restatement